Decellularized cryopreserved human pericardium: a validation study towards tissue bank practice
- PMID: 36696047
- PMCID: PMC11142958
- DOI: 10.1007/s10561-023-10072-6
Decellularized cryopreserved human pericardium: a validation study towards tissue bank practice
Abstract
Pericardial patches are currently used as reconstructive material in cardiac surgery for surgical treatment of cardiac septal defects. Autologous pericardial patches, either treated with glutaraldehyde or not, can be used as an alternative to synthetic materials or xenograft in congenital septal defects repair. The availability of an allogenic decellularized pericardium could reduce complication during and after surgery and could be a valid alternative. Decellularization of allogenic tissues aims at reducing the immunogenic reaction that might trigger inflammation and tissue calcification over time. The ideal graft for congenital heart disease repair should be biocompatible, mechanically resistant, non-immunogenic, and should have the ability to growth with the patients. The aim of the present study is the evaluation of the efficacy of a new decellularization protocol of homologous pericardium, even after cryopreservation. The technique has proven to be suitable as a tissue bank procedure and highly successful in the removal of cells and nucleic acids content, but also in the preservation of collagen and biomechanical properties of the human pericardium.
Keywords: Allograft; Cardiac septal defects; Decellularization; Pericardium; Tissue bank.
© 2023. The Author(s).
Conflict of interest statement
The authors have no competing interests to declare that are relevant to the content of this article.
Figures








Similar articles
-
Pericardium decellularization in a one-day, two-step protocol.Mol Cell Biochem. 2025 Mar;480(3):1819-1829. doi: 10.1007/s11010-024-05086-x. Epub 2024 Sep 10. Mol Cell Biochem. 2025. PMID: 39251464 Free PMC article.
-
Mechanical compliance and immunological compatibility of fixative-free decellularized/cryopreserved human pericardium.PLoS One. 2013 May 21;8(5):e64769. doi: 10.1371/journal.pone.0064769. Print 2013. PLoS One. 2013. PMID: 23705010 Free PMC article.
-
Development and validation of cryopreserved or freeze-dried decellularized human dermis for transplantation.Cell Tissue Bank. 2024 Jun;25(2):685-695. doi: 10.1007/s10561-024-10131-6. Epub 2024 Feb 21. Cell Tissue Bank. 2024. PMID: 38381276 Free PMC article.
-
Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability.Acta Biomater. 2019 Jan 15;84:208-221. doi: 10.1016/j.actbio.2018.10.026. Epub 2018 Oct 17. Acta Biomater. 2019. PMID: 30342283
-
Crosslinking strategies of decellularized extracellular matrix in tissue regeneration.J Biomed Mater Res A. 2024 May;112(5):640-671. doi: 10.1002/jbm.a.37650. Epub 2023 Nov 22. J Biomed Mater Res A. 2024. PMID: 37990863 Review.
Cited by
-
Recent Advances in Hydrogel-Based 3D Bioprinting and Its Potential Application in the Treatment of Congenital Heart Disease.Biomolecules. 2024 Jul 18;14(7):861. doi: 10.3390/biom14070861. Biomolecules. 2024. PMID: 39062575 Free PMC article. Review.
-
Pericardium decellularization in a one-day, two-step protocol.Mol Cell Biochem. 2025 Mar;480(3):1819-1829. doi: 10.1007/s11010-024-05086-x. Epub 2024 Sep 10. Mol Cell Biochem. 2025. PMID: 39251464 Free PMC article.
-
Cardiovascular patches applied in congenital cardiac surgery: Current materials and prospects.Bioeng Transl Med. 2024 Sep 30;10(1):e10706. doi: 10.1002/btm2.10706. eCollection 2025 Jan. Bioeng Transl Med. 2024. PMID: 39801761 Free PMC article. Review.
-
Current State and Challenges of Tissue and Organ Cryopreservation in Biobanking.Int J Mol Sci. 2024 Oct 16;25(20):11124. doi: 10.3390/ijms252011124. Int J Mol Sci. 2024. PMID: 39456905 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources